FDA draft guidance suggests comparing bispecifics to monospecific antibodies

FDA draft guidance suggests comparing bispecifics to monospecific antibodies

Source: 
BioCentury
snippet: 

Demonstrated efficacy of a bispecific antibody against monospecific products targeting the different antigens could be a requirement for gaining FDA approval, according to draft guidance released Thursday.